The COVID-19 subvariant BA.3.2, informally known as 'Cicada,' is gaining attention from health experts due to its potential impact on children aged 3 to 15. Initially reported in South Africa in late 2024, this variant has re-emerged in various countries following a period of decline. While it currently accounts for about 30% of COVID cases in parts of Europe, it has not yet become the dominant strain in the United States, where the Centers for Disease Control and Prevention (CDC) is actively monitoring its spread. BA.3.2 has been detected in at least 23 countries and in wastewater samples across 25 U.S. states. Symptoms reported are largely consistent with previous Omicron variants, including cough, fatigue, fever, and body aches. Notably, Dr. Tulio de Oliveira, a leading researcher at the Center for Epidemic Response and Innovation, has highlighted that children may be significantly more likely to contract this variant compared to others, raising concerns about its transmission patterns.